Potential antipsychotic agents. 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds
- 1 April 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 33 (4), 1155-1163
- https://doi.org/10.1021/jm00166a012
Abstract
A series of 3-substituted 5,6-dimethoxysalicylamides III (9-13 and 15) has been synthesized from the corresponding 2,5,6-trimethoxybenzoic acids. Relaxation times T1 and carbon chemical shifts of the methoxy groups in III showed that the 6-methoxy group adopts a nearly perpendicular orientation and the 5-methoxy group takes on a more coplanar orientation with respect to the ring plane in solution. The salicylamides III display a very high and stereoselective affinity for the [3H]spiperone and [3H]raclopride binding sites in vitro. Regioisomeric salicylamides IV also exhibit pronounced, but lower than III, affinity for the [3H]spiperone binding site. The structural requirements were further assessed by studies of the related amino analogues 23 and 24 and hydroxy analogue 27. The 3-bromo compound 11 (FLB 463) was studied in various in vivo models and compared with the dopamine-D2 antagonists sulpiride, raclopride, eticlopride, and haloperidol. The high potency of 11 to selectively block dopamine-D2 receptors in vitro and in vivo combined with indications on a low potential for motor side effects makes it a very interesting new member of the class of substituted salicylamides.This publication has 21 references indexed in Scilit:
- Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PETScience, 1986
- Preparation of tritium labelled benzamide dopamine‐D2 lignads at high specific activityJournal of Labelled Compounds and Radiopharmaceuticals, 1985
- Specific in vitro and in vivo binding of 3H-raclopride a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brainBiochemical Pharmacology, 1985
- Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography.Proceedings of the National Academy of Sciences, 1985
- Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brainEuropean Journal of Pharmacology, 1984
- Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamidesJournal of Pharmacy and Pharmacology, 1984
- NMR Conformational Study of Aminoalkylbenzamides, Aminoalkyl‐o‐anisamides, and Metoclopramide, a Dopamine Receptor AntagonistHelvetica Chimica Acta, 1984
- Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activitiesJournal of Medicinal Chemistry, 1982
- SUBSTITUTED BENZAMIDE DRUGS AS SELECTIVE NEUROLEPTIC AGENTS1981
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980